Vaxcyte, Inc. PCVX Payments to Acquire Manufacturing Facility and Equipment
Payments to Acquire Manufacturing Facility and Equipment at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept pcvx:PaymentsToAcquireManufacturingFacilityAndEquipment.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s payments to acquire manufacturing facility and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s payments to acquire manufacturing facility and equipment?
- Vaxcyte, Inc. (PCVX) reported payments to acquire manufacturing facility and equipment of $12.69M in Q1 2026.
- How has Vaxcyte, Inc.'s payments to acquire manufacturing facility and equipment changed year-over-year?
- Vaxcyte, Inc.'s payments to acquire manufacturing facility and equipment decreased by 40.5% year-over-year, from $21.33M to $12.69M.
- What does payments to acquire manufacturing facility and equipment mean?
- This represents the cash outflows dedicated to the construction, purchase, or significant upgrade of manufacturing facilities and specialized production equipment. It reflects the company's capital intensity and investment in scaling its internal production capabilities. High levels of this expenditure indicate a strategic focus on building long-term manufacturing infrastructure.